Trial Profile
Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer
Status:
Discontinued
Phase of Trial:
Phase I/II
Latest Information Update: 28 Oct 2015
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Paclitaxel (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 23 Oct 2015 Status changed from recruiting to discontinued, as reported by ClinicalTrials.gov.
- 01 Oct 2012 New trial record